These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
308 related items for PubMed ID: 20730719
1. High concentrations of B-type natriuretic peptide and left ventricular diastolic dysfunction in patients with paroxysmal/persistent atrial fibrillation as possible markers of conversion into permanent form of arrhythmia: 1-year prospective evaluation. Dabrowski R, Borowiec A, Janas J, Firek B, Kowalik I, Smolis-Bak E, Luczak D, Sosnowski C, Kazimierska B, Szwed H. Kardiol Pol; 2010 Aug; 68(8):893-900. PubMed ID: 20730719 [Abstract] [Full Text] [Related]
3. Effects of exercise testing on natriuretic peptide secretion in patients with atrial fibrillation. Wozakowska-Kapłon B, Opolski G. Kardiol Pol; 2009 Mar; 67(3):254-61. PubMed ID: 19378231 [Abstract] [Full Text] [Related]
4. The predictive value of plasma brain natriuretic peptide for the recurrence of atrial fibrillation six months after external cardioversion. Ari H, Binici S, Ari S, Akkaya M, Koca V, Bozat T, Gürdoğan M. Turk Kardiyol Dern Ars; 2008 Oct; 36(7):456-60. PubMed ID: 19155659 [Abstract] [Full Text] [Related]
5. Effect of sinus rhythm restoration after electrical cardioversion on apelin and brain natriuretic Peptide prohormone levels in patients with persistent atrial fibrillation. Kallergis EM, Manios EG, Kanoupakis EM, Mavrakis HE, Goudis CA, Maliaraki NE, Saloustros IG, Milathianaki ME, Chlouverakis GI, Vardas PE. Am J Cardiol; 2010 Jan 01; 105(1):90-4. PubMed ID: 20102897 [Abstract] [Full Text] [Related]
7. Ability of B-type natriuretic peptide in predicting postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting. Ata Y, Turk T, Ay D, Eris C, Demir M, Ari H, Ata F, Yavuz S, Ozyazicioglu A. Heart Surg Forum; 2009 Aug 01; 12(4):E211-6. PubMed ID: 19683991 [Abstract] [Full Text] [Related]
8. The diagnostic utility of N-terminal pro-B-type natriuretic peptide for the detection of major structural heart disease in patients with atrial fibrillation. Shelton RJ, Clark AL, Goode K, Rigby AS, Cleland JG. Eur Heart J; 2006 Oct 01; 27(19):2353-61. PubMed ID: 16952921 [Abstract] [Full Text] [Related]
9. Decreased plasma brain natriuretic peptide levels after a successful maze procedure. Watanabe M, Murakami M, Furukawa H, Nakahara H, Tanaka H, Sunamori M. J Heart Valve Dis; 2003 May 01; 12(3):287-91. PubMed ID: 12803326 [Abstract] [Full Text] [Related]
13. The influence of left ventricle diastolic function on natriuretic peptides levels in patients with atrial fibrillation. Bakowski D, Wozakowska-Kaplon B, Opolski G. Pacing Clin Electrophysiol; 2009 Jun 01; 32(6):745-52. PubMed ID: 19545336 [Abstract] [Full Text] [Related]
14. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure. Koç M, Bozkurt A, Yildiray-Sahin D, Unal I, Acartürk E. Cardiol J; 2009 Jun 01; 16(1):43-9. PubMed ID: 19130415 [Abstract] [Full Text] [Related]
19. Natriuretic peptides as markers of preclinical cardiac disease in obesity. Grandi AM, Laurita E, Selva E, Piantanida E, Imperiale D, Giovanella L, Guasti L, Venco A. Eur J Clin Invest; 2004 May 01; 34(5):342-8. PubMed ID: 15147331 [Abstract] [Full Text] [Related]